Company / Current Assets
Pacira BioSciences, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$548.0M
FY2025
5-year range
$498.3M / $866.0M
FY2021-FY2025
Trend
-26.5%
vs FY2024
Sector context
#107 of 213
Health Care
What the data says
At $548M, Pacira BioSciences, Inc.'s current assets ranks #107 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $243M in FY2016 to $866M in FY2021.
Based on SEC 10-K filings.
$548M in FY2025 with a 5-year CAGR of -3.4%.
Improved from $510M to $548M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +3.2%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#107 of 213 in Health CareTop 50% of 213This company $548.0M Sector average $2.5B
▼
-78.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, current assets decreased 26.5% year-over-year.
- Ranks #107 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $548.0M | -26.5% |
| FY2024 | $745.1M | +46.1% |
| FY2023 | $510.0M | +2.3% |
| FY2022 | $498.3M | -42.5% |
| FY2021 | $866.0M | +32.9% |
| FY2020 | $651.6M | +59.5% |
| FY2019 | $408.6M | -14.5% |
| FY2018 | $478.0M | +22.2% |
| FY2017 | $391.1M | +60.9% |
| FY2016 | $243.1M | -3.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026